The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Recognition and management of fatty acid oxidation defects: A series of 107 patients
Abstract
In a personal series of 107 patients, we describe clinical presentations, methods of recognition and therapeutic management of inherited fatty acid oxidation (FAO) defects. As a whole, FAO disorders appear very severe: among the 107 patients, only 57 are still living. Including 47 siblings who died early in infancy, in total 97 patients died, of whom 30% died within the first week of life and 69% before 1 year. Twenty‐eight patients presented in the neonatal period with sudden death, heart beat disorders, or neurological distress with various metabolic disturbances. Hepatic presentations were observed in 73% of patients (steatosis, hypoketotic hypoglycaemia, hepatomegaly, Reye syndrome). True hepatic failure was rare (10%); cholestasis was observed in one patient with LCHAD deficiency. Cardiac presentations were observed in 51% of patients: 67% patients presented with cardiomyopathy, mostly hypertrophic, and 47% of patients had heart beat disorders with various conduction abnormalities and arrhythmias responsible for collapse, near‐miss and sudden unexpected death. All enzymatic blocks affecting FAO except CPT I and MCAD were found associated with cardiac signs. Muscular signs were observed in 51% of patients (of whom 64% had myalgias or paroxysmal myoglobinuria, and 29% had progressive proximal myopathy). Chronic neurologic presentation was rare, except in LCHAD deficiency (retinitis pigmentosa and peripheral neuropathy). Renal presentation (tubulopathy) and transient renal failure were observed in 27% of patients. The diagnosis of FAO disorders is generally based on the plasma acylcarnitine profile determined by FAB‐MS/MS from simple blood spots collected on a Guthrie card. Urinary organic acid profile and total and free plasma carnitine can also be very helpful, mostly in acute attacks. If there is no significant disturbance between attacks, the diagnosis is based upon a long‐chain fatty acid loading test, fasting test, and in vitro studies of fatty acid oxidation on fresh lymphocytes or cultured fibroblasts. Treatment includes avoiding fasting or catabolism, suppressing lipolysis, and carnitine supplementation. The long‐term dietary therapy aims to prevent periods of fasting and restrict long‐chain fatty acid intake with supplementation of medium‐chain triglycerides. Despite these therapeutic measures, the long‐term prognosis remains uncertain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Millington, D. S., Kodo, N., Norwood, D. L., & Roe, C. R. (1990) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799385 · Cited by 571
Carnitine Deficiency of Human Skeletal Muscle with Associated Lipid Storage Myopathy: A New Syndrome
Engel, A. G., & Angelini, C. (1973) · Science · doi:10.1126/science.179.4076.899 · Cited by 512
Muscle Carnitine Palmityltransferase Deficiency and Myoglobinuria
DiMauro, S., & DiMauro, P. M. M. (1973) · Science · doi:10.1126/science.182.4115.929 · Cited by 477
Peto, R. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90791-1 · Cited by 266
Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake
Stanley, C. A., DeLeeuw, S., Coates, P. M., Vianey‐Liaud, C., Divry, P., Bonnefont, J., Saudubray, J., Haymond, M., Trefz, F. K., Breningstall, G. N., et al. (1991) · Annals of Neurology · doi:10.1002/ana.410300512 · Cited by 213
Self-citationProphylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation.
Corr, P. B., Creer, M. H., Yamada, K. A., Saffitz, J. E., & Sobel, B. E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113978 · Cited by 206
Boles, R. G., Buck, E. A., Blitzer, M. G., Platt, M. S., Cowan, T. M., Martin, S. K., Yoon, H.-R., Madsen, J. A., Reyes-Mugica, M., & Rinaldo, P. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70385-3 · Cited by 202
Demaugre, F., Bonnefont, J. P., Colonna, M., Cepanec, C., Leroux, J. P., & Saudubray, J. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115090 · Cited by 198
Self-citationFasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiency
Bougnères, P.-F., Saudubray, J.-M., Marsac, C., Bernard, O., Odièvre, M., & Girard, J. (1981) · The Journal of Pediatrics · doi:10.1016/s0022-3476(81)80834-7 · Cited by 180
Self-citation
Cited by
A general introduction to the biochemistry of mitochondrial fatty acid β‐oxidation
Houten, S. M., & Wanders, R. J. A. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9061-2 · Cited by 1,020
The Biochemistry and Physiology of Mitochondrial Fatty Acid β-Oxidation and Its Genetic Disorders
Houten, S. M., Violante, S., Ventura, F. V., & Wanders, R. J. A. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105045 · Cited by 920
Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects
BONNEFONT, J. (2004) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2004.06.004 · Cited by 637
Self-citationWarren, J. D., Blumbergs, P. C., & Thompson, P. D. (2002) · Muscle & Nerve · doi:10.1002/mus.10053 · Cited by 431
Control of mitochondrial β-oxidation flux
Eaton, S. (2002) · Progress in Lipid Research · doi:10.1016/s0163-7827(01)00024-8 · Cited by 411
Metadata
- Authors
- Saudubray, J. M., Martin, D., De Lonlay, P., Touati, G., Poggi‐Travert, F., Bonnet, D., Jouvet, P., Boutron, M., Slama, A., Vianey‐Saban, C., Bonnefont, J. P., Rabier, D., Kamoun, P., & Brivet, M.
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 1999-06
- Volume
- 22
- Issue
- 4
- Pages
- 487-502
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W1547384695
- Cited by
- 333
- References
- 37
- FWCI
- 10.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recognition and management of fatty acid oxidation defects: A series of 107 patients. https://app.cochat.ai/papers/10.1023/a:1005556207210
- The paper
- Saudubray, J. M., Martin, D., De Lonlay, P., Touati, G., Poggi‐Travert, F., Bonnet, D., Jouvet, P., Boutron, M., Slama, A., Vianey‐Saban, C., Bonnefont, J. P., Rabier, D., Kamoun, P., & Brivet, M. (1999). Recognition and management of fatty acid oxidation defects: A series of 107 patients. Journal of Inherited Metabolic Disease. https://doi.org/10.1023/a%3A1005556207210
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.